JULY 12, 2024

Expert Picks From DDW 2024, Part 1: IBD, EoE, NERD and More

img-button

In this installment of Expert Picks from DDW 2024, Anisa Shaker, MD, the director of the Swallowing and Esophageal Disorders Center and an associate professor of medicine in the Division of Gastrointestinal and Liver Diseases at the University of Southern California Keck School of Medicine, in Los Angeles, discusses five of her favorite abstracts and presentations from the meeting.


759. The efficacy and safety of guselkumab as maintenance therapy in patients with moderately to severely active